Figure 6
Working model of the therapeutic effects of CAY10594 against APAP-induced acute liver injury. CAY10594 blocks GSK-3β (Serine 9)/JNK phosphorylation in hepatocytes, eliciting therapeutic effects against APAP-induced acute liver injury model.
Figure 6 | Scientific Reports
